Nibroxane

Nibroxane

SCHEMBL379346

CC1OCC(Br)([N+](=O)[O-])CO1

nearest known ligand 0.55

Full drug profile on Sugi Atlas →

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
KCNA4 P22459 2/20 0.55
KCNA1 Q09470 2/20 0.55
KCNAB1 Q14722 2/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11677295 0.78 KCNA4 (0.50) KCNA4KCNA1KCNAB1
SCHEMBL11676480 0.78 KCNA4 (0.50) KCNA4KCNA1KCNAB1
SCHEMBL11117151 0.75 KCNA4 (0.49) KCNA4KCNA1KCNAB1
SCHEMBL10863636 0.75 KCNA4 (0.49) KCNA4KCNA1KCNAB1
SCHEMBL11119335 0.75 KCNA4 (0.47) KCNA4KCNA1KCNAB1
SCHEMBL10447506 0.71 KCNA4 (1.00) KCNA4KCNA1KCNAB1
SCHEMBL28752635 0.71 KCNA4 (0.45) KCNA4KCNA1KCNAB1
SCHEMBL10903521 0.70 KCNA4 (0.42) KCNA4KCNA1KCNAB1
SCHEMBL97282 0.70 KCNA4 (0.56) KCNA4KCNA1KCNAB1
SCHEMBL9176423 0.69

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 379 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9016221-B2 Surface topographies for non-toxic bioadhesion control UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) 2015-04-28 US claimed
US-8268352-B2 Modified release composition for highly soluble drugs TORRENT PHARMACEUTICALS LIMITED (IN) 2012-09-18 US claimed
US-8263125-B2 Dosage form for high dose-high solubility active ingredients that provides for immediate release and modified release of the active ingredients TORRENT PHARMACEUTICALS LIMITED (IN) 2012-09-11 US claimed
US-20100226943-A1 SURFACE TOPOGRAPHIES FOR NON-TOXIC BIOADHESION CONTROL UNIVERSITY OF FLORIDA (US) 2010-09-09 US claimed
CN-101330905-A Freeze-drying process and products obtained thereby SCIDOSE LLC (US) 2008-12-24 CN claimed
EP-1954244-A1 LYOPHILIZATION PROCESS AND PRODUCTS OBTAINED THEREBY Scidose, Llc (US) 2008-08-13 EP claimed
WO-2007061529-A1 LYOPHILIZATION PROCESS AND PRODUCTS OBTAINED THEREBY SCIDOSE LLC. (US) 2007-05-31 WO claimed
US-20070116729-A1 Lyophilization process and products obtained thereby SCIDOSE LLC 2007-05-24 US claimed
US-20060024365-A1 Novel dosage form VAYA NAVIN 2006-02-02 US claimed
US-20060018933-A1 Novel drug delivery system TORRENT PHARMACEUTICALS LIMITED (IN) 2006-01-26 US claimed
US-20060018934-A1 Novel drug delivery system TORRENT PHARMACEUTICALS LIMITED (IN) 2006-01-26 US claimed
EP-0615688-B1 An industrial microbicide and a method for killing microbes for industrial use KATAYAMA CHEMICAL WORKS CO (JP) 1997-11-12 EP claimed
EP-0398795-B1 Aqueous isothiazolone formulation KATAYAMA CHEMICAL WORKS CO (JP) 1996-03-27 EP claimed
EP-0615688-A1 An industrial microbicide and a method for killing microbes for industrial use KATAYAMA CHEMICAL, INC. (JP) 1994-09-21 EP claimed
EP-0398795-A2 Aqueous isothiazolone formulation KATAYAMA CHEMICAL, INC. (JP) 1990-11-22 EP claimed
US-4025533-A BACTERICIDES, FUNGICIDES ELI LILLY AND COMPANY (US) 1977-05-24 US claimed
JP-11171712-A None JP disclosed
EP-4706683-A2 CHEWABLE FORMULATIONS Elanco Tiergesundheit AG (CH) 2026-03-11 EP disclosed
US-4025533-A BACTERICIDES, FUNGICIDES ELI LILLY AND COMPANY (US) 1977-05-24 US disclosed
US-4025533-A BACTERICIDES, FUNGICIDES ELI LILLY AND COMPANY (US) 1977-05-24 US disclosed